N,N-DIMETHYL-1-(METHYLAMINO)CYCLOPROPANECARBOXAMIDE, 95.0%, 250mg

[(3R,6R)-6-methylpiperidin-3-yl]methanol hydrochloride, 98%, 250mg

3-(2-Naphthyl)-D-alanine, >99%, 10g

N-ISOPROPYLOXETAN-3-AMINE, 95.0%, 25g

(R)-2-(2,4-Dichlorophenoxy)propanoic acid, 95%, 1g

2-((2,6-Dichlorophenyl)amino)benzaldehyde, 97%, 1g

(2-(Pyrrolidin-1-yl)pyridin-3-yl)methanamine, 95.0%, 1g

((Allyloxy)carbonyl)-L-valyl-L-alanine, 97%, 10g

4-Methylbenzenesulfonyl azide (30% w/w solution in toluene), 95.0%, 5g

3-Methoxy-3-methyl-1-butanol, min. 99%, for synthesis, 500 ml, glass packaging

2,4-Difluoro-5-methylbenzonitrile, 95.0%, 5g

(S)-3-(6-Methoxy-2-methylsulfanyl-pyrimidin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

2-(benzylamino)-2-cyclopropylacetic acid, 95.0%, 250mg